Free Trial

Reviva Pharmaceuticals (RVPH) Institutional Ownership

Reviva Pharmaceuticals logo
$0.35 -0.44 (-55.73%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$0.35 0.00 (-0.60%)
As of 05/13/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Reviva Pharmaceuticals (NASDAQ:RVPH)

Current
Institutional Ownership
Percentage
63.18%
Number of
Institutional Buyers
(last 12 months)
9
Total
Institutional Inflows
(last 12 months)
$40.71M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$348.49K
Get RVPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Reviva Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

RVPH Institutional Buying and Selling by Quarter

Reviva Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026XTX Topco Ltd164,291$46K0.0%+63.6%0.143%
2/13/2026State Street Corp383,200$107K0.0%+202.4%0.333%
2/9/2026Geode Capital Management LLC1,048,954$293K0.0%+87.6%0.912%
11/17/2025Millennium Management LLC1,711,221$631K0.0%+15.0%2.468%
11/17/2025Lido Advisors LLC99,647$37K0.0%N/A0.144%
11/10/2025 Persistent Asset Partners Ltd593,902$219K0.2%-7.4%0.857%
8/15/2025683 Capital Management LLC1,000,000$381K0.0%N/A2.083%
8/14/2025Armistice Capital LLC2,692,000$1.03M0.0%N/A5.608%
8/12/2025XTX Topco Ltd81,960$31K0.0%N/A0.171%
8/11/2025 Persistent Asset Partners Ltd641,174$244K0.2%+300.0%1.336%
8/8/2025Geode Capital Management LLC448,202$171K0.0%+6.9%0.934%
5/16/2025NewEdge Advisors LLC60,900$58K0.0%N/A0.130%
5/5/2025Private Advisor Group LLC200,000$191K0.0%N/A0.428%
5/2/2025BluePointe Capital Management LLC47,185$45K0.0%+354.7%0.101%
2/17/2025Tang Capital Management LLC170,000$308K0.0%N/A0.508%
2/17/2025Millennium Management LLC1,804,488$3.27M0.0%-1.5%5.396%
2/17/2025Focus Partners Wealth60,000$109K0.0%-62.7%0.179%
2/17/2025Cornerstone Select Advisors LLC17,500$32K0.0%N/A0.052%
2/17/2025Ameriprise Financial Inc.46,467$84K0.0%N/A0.139%
2/14/2025Schonfeld Strategic Advisors LLC1,058,100$1.92M0.0%-30.2%3.164%
2/14/2025Tower Research Capital LLC TRC26,775$48K0.0%+848.8%0.080%
2/13/2025XTX Topco Ltd25,020$45K0.0%N/A0.075%
2/13/2025Raymond James Financial Inc.14,000$25K0.0%N/A0.042%
2/12/2025Geode Capital Management LLC311,701$564K0.0%+11.9%0.932%
2/6/2025Raymond James Financial Inc.14,000$25K0.0%N/A0.042%
1/23/2025EMC Capital Management44,535$81K0.0%+142.0%0.133%
1/22/2025Drive Wealth Management LLC20,000$36K0.0%N/A0.060%
11/16/2024Geode Capital Management LLC278,496$401K0.0%+17.9%0.833%
5/10/2024Vanguard Group Inc.1,001,836$3.79M0.0%+2.8%3.588%
2/13/2024Armistice Capital LLC1,764,000$9.09M0.1%+194.0%6.318%
1/30/2024Vontobel Holding Ltd.14,000$72K0.0%N/A0.062%
11/15/2023Armistice Capital LLC600,000$2.93M0.0%-27.2%2.649%
11/9/2023EMC Capital Management123,915$613K0.4%+1,294.3%0.547%
8/7/2023Wolverine Asset Management LLC14,501$85K0.0%+137.6%0.071%
7/27/2023Virtu Financial LLC18,448$108K0.0%N/A0.090%
2/15/2023Tang Capital Management LLC24,125$103K0.0%N/A0.118%
2/13/2023EMC Capital Management123,915$527K0.5%+125.0%0.606%
2/1/2023Wolverine Asset Management LLC6,814$29K0.0%+934.0%0.033%
11/7/2022Virtu Financial LLC46,119$73K0.0%N/A0.226%
10/25/2022Raymond James & Associates33,000$52K0.0%+65.0%0.161%
The one number Musk can't hide in the S-1 (Ad)

When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requires more electricity than some small countries use in a year, and SEC rules require it be disclosed. When that figure goes public, every analyst on Wall Street will race to identify the supplier. One small company already has a $1.5 billion backlog - and Dylan Jovine has the name and ticker.tc pixel

See the stock the SpaceX S-1 filing is likely to expose
2/10/2022EMC Capital Management55,078$159K0.1%-27.4%0.364%


RVPH Institutional Ownership - Frequently Asked Questions

During the previous two years, 20 institutional investors and hedge funds held shares of Reviva Pharmaceuticals. The most heavily invested institutionals were Schonfeld Strategic Advisors LLC ($1.92M), Armistice Capital LLC ($1.03M), Millennium Management LLC ($631K), 683 Capital Management LLC ($381K), Tang Capital Management LLC ($308K), Geode Capital Management LLC ($293K), and Persistent Asset Partners Ltd ($219K).Learn more on Reviva Pharmaceuticals' institutional investors.

63.18% of Reviva Pharmaceuticals' stock is owned by institutional investors. Learn more on RVPH's institutional investor holdings.

Of the 18 institutional investors that purchased Reviva Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($2.69M), 683 Capital Management LLC ($1M), Geode Capital Management LLC ($594.36K), Persistent Asset Partners Ltd ($480.86K), State Street Corp ($256.50K), Millennium Management LLC ($223.18K), and Private Advisor Group LLC ($200K).

Institutional investors have bought a total of 5,477,716 shares in the last 24 months. This purchase volume represents approximately $40.71M in transactions.

The following institutional investors have sold Reviva Pharmaceuticals stock in the last 24 months: Persistent Asset Partners Ltd ($47.27K).

Institutional investors have sold a total of 47,272 shares in the last 24 months. This volume of shares sold represents approximately $348.49K in transactions.



This page (NASDAQ:RVPH) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners